PUBLISHER: The Business Research Company | PRODUCT CODE: 1946658
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946658
Ophthalmic medical lasers are used to treat a range of eye diseases, offering precise and minimally invasive treatment options. These lasers improve patient outcomes by reducing recovery times and enhancing the effectiveness of various ophthalmic procedures, such as surgeries for glaucoma, cataracts, and retinal conditions.
The primary products within the field of ophthalmic medical lasers include diode lasers, femtosecond lasers, excimer lasers for aromatherapy, ND:YAG lasers, and other laser systems. Diode lasers are semiconductor devices that generate coherent radiation with the same frequency and phase, typically in either the visible or infrared spectrum, through the use of a p-n junction. These ophthalmic medical lasers find applications in a range of medical procedures, including refractive error correction, cataract removal, the treatment of diabetic retinopathy, glaucoma, age-related macular degeneration, and other ophthalmic conditions. These lasers are employed by various healthcare facilities, including hospitals, specialized ophthalmology clinics, and ambulatory surgery centers, to provide effective eye care and treatment.
Tariffs are impacting the ophthalmic medical lasers market by increasing costs of imported optical components, laser diodes, precision sensors, and advanced control electronics used in femtosecond, excimer, and ND:YAG laser systems. Hospitals and specialty clinics in North America and Europe are most affected due to dependence on imported high-precision laser assemblies, while Asia-Pacific faces higher manufacturing and export-related costs. These tariffs are increasing capital expenditure for healthcare providers and slowing equipment replacement cycles. However, they are also encouraging localized assembly, regional supplier partnerships, and domestic production of ophthalmic laser components, supporting long-term supply chain resilience.
The ophthalmic medical lasers market research report is one of a series of new reports from The Business Research Company that provides ophthalmic medical lasers market statistics, including ophthalmic medical lasers industry global market size, regional shares, competitors with a ophthalmic medical lasers market share, detailed ophthalmic medical lasers market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic medical lasers industry. This ophthalmic medical lasers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ophthalmic medical lasers market size has grown strongly in recent years. It will grow from $1.33 billion in 2025 to $1.43 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increasing prevalence of age-related eye disorders, rising adoption of laser-based ophthalmic treatments, expansion of specialty eye clinics, improvements in laser safety standards, growing acceptance of outpatient eye procedures.
The ophthalmic medical lasers market size is expected to see strong growth in the next few years. It will grow to $1.89 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing demand for advanced vision correction solutions, rising investments in ophthalmic laser innovation, expansion of laser-assisted surgeries in emerging markets, growing focus on personalized eye treatments, increasing adoption of AI-assisted laser guidance. Major trends in the forecast period include increasing adoption of minimally invasive laser procedures, rising use of femtosecond lasers in cataract surgery, growing precision in refractive error correction, expansion of multi-wavelength laser platforms, enhanced focus on faster patient recovery.
The growing elderly population is anticipated to drive the expansion of the ophthalmic medical lasers market in the coming years. The elderly population comprises individuals aged 65 years and above. The rise in the elderly population is attributed to increased life expectancy and improved overall survival, leading to a higher proportion of older adults within the population. Ophthalmic medical lasers are utilized for the elderly population to perform procedures such as cataract surgery, glaucoma treatment, age-related macular degeneration (AMD) management, diabetic retinopathy treatment, refractive lens exchange, and other ophthalmic interventions. For example, in October 2025, according to the World Health Organization, a Switzerland-based health organization, by 2030, one in six people globally (approximately 1.4 billion) will be aged 60 years or older. Additionally, by 2050, this figure is expected to double, reaching 2.1 billion older adults worldwide.
Major companies operating in the ophthalmic medical lasers market are concentrating on developing innovative advancements, including next-generation intraoperative radiotherapy (IORT) platforms, to improve precision, workflow efficiency, and patient safety during cancer treatment procedures. Next-generation IORT platforms are advanced systems that deliver targeted radiation directly to the tumor site during surgery, reducing exposure to surrounding healthy tissues while allowing more controlled and efficient treatment. For example, in April 2025, ZEISS, a Germany-based medical technology company, received FDA 510(k) clearance for its INTRABEAM 700 system, a robotic-assisted IORT solution developed to deliver highly focused radiation therapy for neuro-oncology and breast cancer surgeries. The platform incorporates enhanced imaging integration, optimized ergonomics, and increased control during radiation delivery, helping surgeons achieve more precise intraoperative treatment.
In July 2024, Alcon, a Switzerland-based healthcare company, acquired BELKIN Vision for an undisclosed amount. This acquisition aims to expand Alcon's glaucoma portfolio and enhance global access to first-line laser treatment for glaucoma patients. BELKIN Vision, an Israel-based medical technology company, specializes in developing innovative laser treatments.
Major companies operating in the ophthalmic medical lasers market are Alcon Laboratories Inc., Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Topcon Corporation, Ziemer Ophthalmic Systems AG, IRIDEX Corporation, NIDEK Co. Ltd., Lumenis Ltd., Johnson & Johnson Surgical Vision Inc., Lumibird Medical, Quantel Inc., Coherent Inc., Ocular Instruments Inc., Ellex Medical Lasers Limited, LENSAR LLC, LIGHTMED Corporation, Menicon Co. Ltd., Novartis AG, Omeros Corporation, Oxurion NV, Regeneron Pharmaceuticals Inc., Roche Holding AG, Rohto Pharmaceutical Co. Ltd., Santen Pharmaceuticals, SCHWIND eye-tech-solutions GmbH & Co. KG, Staar Surgical Company, ThromboGenics NV
North America was the largest region in the ophthalmic medical lasers market in 2025. Asia-Pacific was the second-largest region in the ophthalmic medical lasers market report. The regions covered in the ophthalmic medical lasers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the ophthalmic medical lasers market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The ophthalmic medical lasers market consists of sales of instruments such as SLT lasers, excimer lasers, cyclodiode lasers, and femtosecond lasers. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ophthalmic Medical Lasers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses ophthalmic medical lasers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ophthalmic medical lasers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ophthalmic medical lasers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.